Nigel D. Toussaint

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update

Markus Ketteler, Geoffrey A. Block, Pieter Evenepoel et al. · Annals of Internal Medicine · 2018 · 312 citations · Full text

Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease

Nigel D. Toussaint, Kenneth K. Lau, Boyd J. Strauss et al. · Nephrology Dialysis Transplantation · 2007 · 247 citations · Full text

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

Jonathan Barratt, Richard Lafayette, Jens Kristensen et al. · Kidney International · 2022 · 205 citations · Full text

<scp>KHA‐CARI</scp> Guideline: Early chronic kidney disease: Detection, prevention and management

David W. Johnson, Emelia Atai, Maria Chan et al. · Nephrology · 2013 · 175 citations · Full text